Amidate(tm) Etomidate
Product Images NDC 51662-1455

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 9 technical images submitted to the FDA as part of the official labeling for Amidate(tm) Etomidate (NDC 51662-1455). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Hf Acquisition Co Llc, Dba Healthfirst, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

How Supplied (How Supplied)

How Supplied (How Supplied)
This is a description of different units of sale for a medication with a concentration of 2 mg/ml. In the first two options, the medication is sold in a tray containing 10 fliptop vials each with a volume/quantity of 20 mg/10 mL and 40mg/20 mL respectively. The third option is a bundle that contains 10 Abboject syringes with a volume/quantity of 20 mL that have a male luer lock adapter and each syringe also contains 40 mg of the medication.*
FDA Label Image
FDA Label Image

Seerialized Labeling (Serialized Labeling)

Seerialized Labeling (Serialized Labeling)
20 mL Single-dose Fliptop Vial used for intravenous injection of RARIMiGiAdlC pp, a medication with the drug code 05479DK. The vial is distributed by HF Acquisition Co. and Hospira, Inc. The user is advised to refer to the manufacturer's package insert for instructions on use.*
FDA Label Image

Structure (Structure)

FDA Label Image

Vial Opt 1 (Vial Label Opt 1)

FDA Label Image

Vial Label Opt 2 (Vial Label Opt 2)

Vial Label Opt 2 (Vial Label Opt 2)
This is a description of an injectable medication in the form of a single-dose fliptop vial. The medication, called Etomidate Injection, USP, contains 2 mg of etomidate and 35% volume/volume of propylene glycol in each 1 mL. It is meant for intravenous use only and is sterile and non-pyrogenic. Additional instructions for dosage are provided in the insert. The manufacturer of this medication is Hospira, Inc. located in Lake Forest, Illinois.*
FDA Label Image

Vial Label Opt 3 (Vial Label Opt 3)

Vial Label Opt 3 (Vial Label Opt 3)
This is a description for a medication called Etomidate Injection, USP that comes in a 20 mL single-dose flip-top vial with a prescription only NDC code. Each milliliter contains 2 mg of etomidate and 35% v/v propylene glycol. The solution is non-pyrogenic. The usual dosage is not available. This medication is for intravenous use only. The manufacturer is Hospira, Inc. and the unused portion should be discarded according to the insert.*
FDA Label Image

Vial Label Opt 4 (Vial Label Opt 4)

Vial Label Opt 4 (Vial Label Opt 4)
This is a description of a 20 mL single-dose fliptop vial containing Etomidate Injection, USP. The NDC number is NDC0409-6695-12. Each mL contains 2 mg of etomidate and 35% v/v propylene glycol. This medication is for intravenous use only and is distributed by Hospira, Inc. The usual dosage information is included in the insert and any unused portion of 40 mg/20 mL should be discarded.*
FDA Label Image

Vial Label Opt 5 (Vial Label Opt 5)

Vial Label Opt 5 (Vial Label Opt 5)
This is a description of a medication. The medication is called "Etomidate Injection, USP". It is contained in a single-dose vial with a flip-top and is only available through prescription. The medication is non-gyrogenic and has a usual dosage which can be found in the insert. Each milliliter of this medication contains 2mg of etomidate and some propylene glycol. The unused portion of this medication should be discarded. The NDC number for this medication is 0409-6695-12 and it is distributed by Hospira, Inc in Lake Forest, IL. The medication is for intravenous use only.*

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.